Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Tarcocimab Tedromer versus sham treatment for diabetic retinopathy is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Tarcocimab Tedromer (Tarcocimab tedromer)

Snippet

Sponsor: Kodiak Sciences Inc | Conditions: Diabetic Retinopathy | Phase 3 | Status: ACTIVE_NOT_RECRUITING